Histogram
Visit number vs Resistin
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Baseline | 49 | 9.6 | ± 3.2 | 9.7 | 3.8 | 18.7 | - | 49 |
| 9-Month Followup | 43 | 9.7 | ± 3.0 | 9.6 | 4.7 | 16.8 | - | 43 |
| 18-Month Followup | 39 | 9.0 | ± 2.6 | 8.8 | 4.8 | 14.3 | 1 | 40 |
Randomized treatment arm vs Resistin
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 49 | 9.6 | ± 3.2 | 9.7 | 3.8 | 18.7 | - | 49 |
| Laparoscopic Gastric Banding (LGB) | 28 | 9.5 | ± 3.3 | 9.6 | 5.0 | 18.7 | - | 28 |
| Continuous Positive Airway Pressure (CPAP) | 21 | 9.9 | ± 3.1 | 9.7 | 3.8 | 16.1 | - | 21 |
Randomized treatment arm vs Resistin
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 43 | 9.7 | ± 3.0 | 9.6 | 4.7 | 16.8 | - | 43 |
| Laparoscopic Gastric Banding (LGB) | 25 | 9.1 | ± 2.8 | 9.4 | 4.7 | 14.3 | - | 25 |
| Continuous Positive Airway Pressure (CPAP) | 18 | 10.5 | ± 3.2 | 10.2 | 6.3 | 16.8 | - | 18 |
Randomized treatment arm vs Resistin
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 39 | 9.0 | ± 2.6 | 8.8 | 4.8 | 14.3 | 1 | 40 |
| Laparoscopic Gastric Banding (LGB) | 23 | 8.7 | ± 2.7 | 8.8 | 4.8 | 14.3 | 1 | 24 |
| Continuous Positive Airway Pressure (CPAP) | 16 | 9.3 | ± 2.5 | 9.4 | 5.0 | 13.4 | - | 16 |
Age of the participant vs Resistin
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 49 | 9.6 | ± 3.2 | 9.7 | 3.8 | 18.7 | - | 49 |
| 27.0 to 45.0 years | 13 | 9.6 | ± 3.2 | 9.7 | 3.8 | 15.4 | - | 13 |
| 46.0 to 50.0 years | 12 | 9.0 | ± 2.6 | 9.3 | 5.8 | 14.0 | - | 12 |
| 51.0 to 56.0 years | 12 | 10.3 | ± 3.6 | 9.3 | 6.8 | 18.7 | - | 12 |
| 57.0 to 65.0 years | 12 | 9.7 | ± 3.3 | 9.7 | 5.0 | 16.1 | - | 12 |
Age of the participant vs Resistin
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 43 | 9.7 | ± 3.0 | 9.6 | 4.7 | 16.8 | - | 43 |
| 28.0 to 47.0 years | 11 | 9.6 | ± 3.2 | 8.5 | 6.0 | 16.8 | - | 11 |
| 47.0 to 52.0 years | 11 | 8.7 | ± 2.0 | 9.1 | 5.2 | 11.7 | - | 11 |
| 52.0 to 58.0 years | 11 | 10.8 | ± 3.4 | 10.4 | 5.9 | 16.5 | - | 11 |
| 58.0 to 65.0 years | 10 | 9.6 | ± 3.2 | 9.8 | 4.7 | 14.5 | - | 10 |
Age of the participant vs Resistin
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 39 | 9.0 | ± 2.6 | 8.8 | 4.8 | 14.3 | 1 | 40 |
| 29.0 to 46.0 years | 10 | 8.6 | ± 2.3 | 8.4 | 5.3 | 11.6 | - | 10 |
| 47.0 to 52.0 years | 10 | 9.0 | ± 2.4 | 9.3 | 5.0 | 13.3 | - | 10 |
| 53.0 to 58.0 years | 10 | 9.2 | ± 3.3 | 9.4 | 5.0 | 14.3 | - | 10 |
| 58.0 to 65.0 years | 9 | 9.0 | ± 2.6 | 8.8 | 4.8 | 13.4 | 1 | 10 |
Gender of the participant vs Resistin
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 49 | 9.6 | ± 3.2 | 9.7 | 3.8 | 18.7 | - | 49 |
| Male | 28 | 9.1 | ± 2.9 | 9.2 | 3.8 | 15.4 | - | 28 |
| Female | 21 | 10.4 | ± 3.5 | 10.4 | 5.8 | 18.7 | - | 21 |
Gender of the participant vs Resistin
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 43 | 9.7 | ± 3.0 | 9.6 | 4.7 | 16.8 | - | 43 |
| Male | 25 | 9.3 | ± 3.4 | 8.6 | 4.7 | 16.8 | - | 25 |
| Female | 18 | 10.3 | ± 2.4 | 10.1 | 6.3 | 14.5 | - | 18 |
Gender of the participant vs Resistin
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 39 | 9.0 | ± 2.6 | 8.8 | 4.8 | 14.3 | 1 | 40 |
| Male | 24 | 8.4 | ± 2.7 | 8.4 | 4.8 | 13.3 | 1 | 25 |
| Female | 15 | 9.9 | ± 2.3 | 9.8 | 6.5 | 14.3 | - | 15 |
Race of the participant vs Resistin
Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 46 | 9.7 | ± 3.2 | 9.7 | 3.8 | 18.7 | - | 46 |
| white | 35 | 10.2 | ± 3.1 | 9.8 | 5.9 | 18.7 | - | 35 |
| american indian or alaska native | - | - | - | - | - | - | - | - |
| black or african american | 9 | 7.9 | ± 2.9 | 6.9 | 5.0 | 14.0 | - | 9 |
| asian | 2 | 8.3 | ± 6.5 | 8.3 | 3.8 | 12.9 | - | 2 |
| native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
| other | - | - | - | - | - | - | - | - |
| multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Resistin
9-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 40 | 9.6 | ± 3.1 | 9.5 | 4.7 | 16.8 | - | 40 |
| white | 31 | 9.9 | ± 3.1 | 9.9 | 5.2 | 16.8 | - | 31 |
| american indian or alaska native | - | - | - | - | - | - | - | - |
| black or african american | 8 | 8.3 | ± 3.0 | 7.8 | 4.7 | 13.9 | - | 8 |
| asian | 1 | 11.4 | - | 11.4 | 11.4 | 11.4 | - | 1 |
| native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
| other | - | - | - | - | - | - | - | - |
| multiple | - | - | - | - | - | - | - | - |
Race of the participant vs Resistin
18-Month Followup
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 36 | 8.9 | ± 2.6 | 8.8 | 4.8 | 14.3 | 1 | 37 |
| white | 29 | 9.1 | ± 2.7 | 8.8 | 5.0 | 14.3 | - | 29 |
| american indian or alaska native | - | - | - | - | - | - | - | - |
| black or african american | 6 | 7.6 | ± 2.3 | 8.0 | 4.8 | 10.8 | 1 | 7 |
| asian | 1 | 10.1 | - | 10.1 | 10.1 | 10.1 | - | 1 |
| native hawaiian or other pacific islander | - | - | - | - | - | - | - | - |
| other | - | - | - | - | - | - | - | - |
| multiple | - | - | - | - | - | - | - | - |